Equities researchers at Deutsche Bank started coverage on shares of Cigna (NYSE:CI) in a research note issued on Thursday, BenzingaRatingsTable reports. The brokerage set a “buy” rating and a $207.00 price target on the health services provider’s stock. Deutsche Bank’s price target indicates a potential upside of 27.86% from the company’s previous close.
CI has been the subject of a number of other research reports. Sanford C. Bernstein upgraded Cigna from a “market perform” rating to an “outperform” rating and set a $205.00 price target for the company in a research note on Tuesday, August 6th. Stephens set a $225.00 price target on shares of Cigna and gave the stock a “buy” rating in a report on Friday, August 23rd. Citigroup reaffirmed a “buy” rating on shares of Cigna in a report on Wednesday, August 21st. ValuEngine cut shares of Cigna from a “hold” rating to a “sell” rating in a report on Tuesday, July 23rd. Finally, Oppenheimer set a $254.00 target price on shares of Cigna and gave the company a “buy” rating in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and sixteen have assigned a buy rating to the stock. Cigna has an average rating of “Buy” and a consensus price target of $214.90.
Shares of NYSE:CI opened at $161.89 on Thursday. The business’s 50 day simple moving average is $160.99 and its 200 day simple moving average is $161.69. The company has a market capitalization of $61.70 billion, a P/E ratio of 11.38, a P/E/G ratio of 0.83 and a beta of 0.73. Cigna has a 1 year low of $141.95 and a 1 year high of $226.60. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.70 and a quick ratio of 0.70.
Cigna (NYSE:CI) last announced its quarterly earnings results on Thursday, August 1st. The health services provider reported $4.30 EPS for the quarter, beating the Zacks’ consensus estimate of $3.74 by $0.56. The company had revenue of $34.38 billion during the quarter, compared to analysts’ expectations of $33.27 billion. Cigna had a return on equity of 13.24% and a net margin of 3.60%. Cigna’s revenue was up 198.9% compared to the same quarter last year. During the same period in the prior year, the company earned $3.89 EPS. On average, sell-side analysts anticipate that Cigna will post 16.75 EPS for the current fiscal year.
In other Cigna news, CEO David Cordani purchased 32,509 shares of Cigna stock in a transaction dated Monday, September 9th. The shares were purchased at an average cost of $155.17 per share, for a total transaction of $5,044,421.53. Corporate insiders own 0.80% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the business. Redhawk Wealth Advisors Inc. bought a new stake in shares of Cigna during the second quarter worth about $28,000. Virtus ETF Advisers LLC purchased a new stake in Cigna in the 2nd quarter valued at $30,000. TRUE Private Wealth Advisors purchased a new stake in Cigna in the 2nd quarter valued at $40,000. Prime Capital Investment Advisors LLC grew its stake in Cigna by 32.5% in the 2nd quarter. Prime Capital Investment Advisors LLC now owns 257 shares of the health services provider’s stock valued at $40,000 after purchasing an additional 63 shares during the period. Finally, Trustcore Financial Services LLC bought a new position in Cigna in the 1st quarter valued at $49,000. 87.46% of the stock is currently owned by institutional investors and hedge funds.
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Story: What are gap-down stocks?
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.